Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 4Terminated 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Thoracic 2Other hematologic neoplasm 2Tumor-Agnostic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Mesothelioma 1Lung Neoplasms 1Emergence Delirium 1Delirium 1

Interventions

Carboplatin 158Pemetrexed 135Cisplatin 115pembrolizumab 99Docetaxel 94Paclitaxel 89Gemcitabine 63Erlotinib Hydrochloride 60Radiotherapy 55Nivolumab 55Bevacizumab 46Etoposide 42atezolizumab 33Radiosurgery 33durvalumab 28Cyclophosphamide 22Vinorelbine 21Ipilimumab 21Radiation 20Taxes 17130-nm albumin-bound paclitaxel 17Albumin-Bound Paclitaxel 16Gefitinib 14Irinotecan 13Drug Therapy 13osimertinib 12avelumab 12Magnetic Resonance Spectroscopy 12Dexamethasone 12Cetuximab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Acetaminophen × Thoracic × Clear all
NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Korea University Guro Hospital

Phase 4 Terminated
25 enrolled
Thoracic

Emergence Delirium, Delirium, Lung Neoplasms

NCT04840615 2024-02-02

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
2 enrolled 14 charts
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡